Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott MacDonald

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
Journal of Substance Abuse Treatment|June 9, 2019
Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periodsEugenia Oviedo-Joekes, Heather Palis, Daphne Guh, et al.
Addiction (Abingdon, England)|March 29, 2018
Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trialNick Bansback, Daphne Guh, Eugenia Oviedo-Joekes, et al.
Scandinavian Journal of Medicine & Science in Sports|December 18, 2024
Evolutionary Mismatch and Lifestyle-Related Diseases: A Study of a 6-Month Intensive Lifestyle InterventionChristopher Scott MacDonald, Mia Aagaard Bennekou, Sabrina Mai Nielsen, et al.
The International Journal on Drug Policy|June 28, 2020
Event-level outcomes of police interactions with young people in three non-metropolitan cities across British Columbia, CanadaKiffer G Card, Marion Selfridge, Alissa M Greer, et al.
BMJ Open|March 12, 2016
Prevalence of alcohol and drug use in injured British Columbia driversJeffrey R Brubacher, Herbert Chan, Walter Martz, et al.
JAMA Psychiatry|April 7, 2016
Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical TrialEugenia Oviedo-Joekes, Daphne Guh, Suzanne Brissette, et al.
Drug and Alcohol Review|June 9, 2017
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependenceEugenia Oviedo-Joekes, Heather Palis, Daphne Guh, et al.
Addiction (Abingdon, England)|July 25, 2024
Client preferences for the design and delivery of injectable opioid agonist treatment services: Results from a best-worst scaling taskRebecca Kathleen Metcalfe, Sophia Dobischok, Nick Bansback, et al.
Substance Abuse Treatment, Prevention, and Policy|May 21, 2017
Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorderHeather Palis, Kirsten Marchand, Daphne Guh, et al.
BMJ Open Diabetes Research & Care|January 14, 2021
One-year intensive lifestyle intervention and improvements in health-related quality of life and mental health in persons with type 2 diabetes: a secondary analysis of the U-TURN randomized controlled trialChristopher Scott MacDonald, Sabrina M Nielsen, Jakob Bjørner, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Journal of Substance Abuse Treatment|June 9, 2019
Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periodsEugenia Oviedo-Joekes, Heather Palis, Daphne Guh, et al.
Addiction (Abingdon, England)|March 29, 2018
Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trialNick Bansback, Daphne Guh, Eugenia Oviedo-Joekes, et al.
Scandinavian Journal of Medicine & Science in Sports|December 18, 2024
Evolutionary Mismatch and Lifestyle-Related Diseases: A Study of a 6-Month Intensive Lifestyle InterventionChristopher Scott MacDonald, Mia Aagaard Bennekou, Sabrina Mai Nielsen, et al.
The International Journal on Drug Policy|June 28, 2020
Event-level outcomes of police interactions with young people in three non-metropolitan cities across British Columbia, CanadaKiffer G Card, Marion Selfridge, Alissa M Greer, et al.
BMJ Open|March 12, 2016
Prevalence of alcohol and drug use in injured British Columbia driversJeffrey R Brubacher, Herbert Chan, Walter Martz, et al.
JAMA Psychiatry|April 7, 2016
Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical TrialEugenia Oviedo-Joekes, Daphne Guh, Suzanne Brissette, et al.
Drug and Alcohol Review|June 9, 2017
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependenceEugenia Oviedo-Joekes, Heather Palis, Daphne Guh, et al.
Addiction (Abingdon, England)|July 25, 2024
Client preferences for the design and delivery of injectable opioid agonist treatment services: Results from a best-worst scaling taskRebecca Kathleen Metcalfe, Sophia Dobischok, Nick Bansback, et al.
Substance Abuse Treatment, Prevention, and Policy|May 21, 2017
Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorderHeather Palis, Kirsten Marchand, Daphne Guh, et al.
BMJ Open Diabetes Research & Care|January 14, 2021
One-year intensive lifestyle intervention and improvements in health-related quality of life and mental health in persons with type 2 diabetes: a secondary analysis of the U-TURN randomized controlled trialChristopher Scott MacDonald, Sabrina M Nielsen, Jakob Bjørner, et al.
Pageof 14